October digital edition 2023

For patients with keratoconus-related inflammation, an intracanalicular steroid insert rivals the effectiveness of eye drops while boosting adherence.

AI may play an important role in patient communication and treatment.

Optometrists must consider the experience of the person in the chair.

The good, the bad, and the questionable.

Retain patients and recapture dropouts with a tandem approach.

Here’s why formulation matters.

Collaboration between ophthalmologists, optometrists can boost early detection.

Private practice eye care providers’ ability to immediately administer antibiotic eye drops or have them overnighted to the patient is a giant step forward for practice and patient.

The first approved GA treatment leaves room for additional therapies.

Innovations in multifocal contact lenses have expanded options.

Results of the BRIO-I study, the first of 2 phase 3 clinical trials of Brimochol PF, a topical, fixed-dose combination for the treatment of presbyopia, have recently been released.

Patients with HTG had significantly fewer mtDNA copies per nuclear DNA.

Understanding the role of virtual staff and considering the pros and cons.